Effects of exogenous prostaglandins on aqueous humor dynamics and blood- aqueous barrier function

Survey of Ophthalmology

Volumn 41, Issue SUPPL. 2, 1997, Pages

  Toris, C B ^a   Camras, C B ^a   Yablonski, M E ^a   Brubaker, R F ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

aqueous humor dynamics; cat; human; latanoprost; monkey; outflow facility; prostaglandin; uveoscleral outflow

Indexed keywords

5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; EYE DROPS; FLUORESCEIN; LATANOPROST; PHDH 100A; PLACEBO; PRODRUG; PROSTAGLANDIN; PROSTAGLANDIN A2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN F2 ALPHA DERIVATIVE; PROSTAGLANDIN F2 ALPHA ISOPROPYL ESTER; PROSTAGLANDIN F2 ALPHA TROMETAMOL; S 1033; TIMOLOL; UNCLASSIFIED DRUG; UNOPROSTONE ISOPROPYL ESTER;

ANTERIOR EYE SEGMENT; AQUEOUS HUMOR FLOW; BLOOD EYE BARRIER; CAT; CILIARY MUSCLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG MECHANISM; EXTRACELLULAR MATRIX; GLAUCOMA; HUMAN; INTRACAMERAL DRUG ADMINISTRATION; INTRAOCULAR HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MONKEY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCLERA; TOPICAL DRUG ADMINISTRATION; UVEA;

EID: 0030906585     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0039-6257(97)80010-0     Document Type: Conference Paper

References (49)

1. A Aim J Villumsen PhXA34, a new potent ocular hypotensive drug. A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers Arch Ophthalmol 109 1991 1564 1568
2. A Alm C Camras P Watson Phase 3 latanoprost studies: Masked 6-month comparisons with timolol, in the United Kingdom, Scandinavia and USA Surv Ophthalmol 41 Suppl 2 1997 S105 S110
3. B Becker Does hyposecretion of aqueous humor damage the trabecular meshwork? J Glaucoma 4 1995 303 305
4. LZ Bito Species differences in the responses of the eye to irritation and trauma: a hypothesis of divergence in ocular defense mechanisms, and the choice of experimental animals for eye research Exp Eye Res 39 1984 807 829
5. LZ Bito Glaucoma: A physiologic perspective with Darwinian overtones J Glaucoma 1 1992 193 205
6. JM Butler WC Unger I Grierson Recent experimental studies on the blood aqueous barrier: The anatomical basis of the responses to injury Eye Suppl 2 1988 S213
7. CB Camras Mechanism of the prostaglandin-induced reduction ofintraocular pressure in humans B Samuelsson Advances in Prostaglandin, Thromboxane, and Leukotriene Research Vol 23 1995 Raven Press Ltd New York 519 525
8. CB Camras A Aim Initial clinical studies with prostaglandins and their analogues Surv Ophthalmol 41 Suppl 2 1997 S61 S68
9. 2α on IOP in glaucomatous monkey eyes (abstract) Invest Ophthalmol Vis Sci (Suppl) 31 1990 150
10. 2α or epinephrine on cynomolgus monkey eyes: III. Histopathology Invest Ophthalmol Vis Sci 29 1988 1428 1436
11. 2α or epinephrine on cynomolgus monkey eyes: I. Aqueous humor dynamics Invest Ophthalmol Vis Sci 28 1987 463 469
12. 2α or epinephrine on cynomolgus monkey eyes: II. Slit-lamp biomicroscopy, aqueous humor analysis, and fluorescein angiography Invest Ophthalmol Vis Sci 28 1987 921 926
13. 2α-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients Ophthalmology 96 1989 1329 1337
14. J Chen DF Woodward Prostaglandin-induced relaxation of precontracted cat ciliary muscle is mediated by EP, and DP receptors Invest Ophthalmol Vis Sci 33 1992 3195 3201
15. 2α on aqueous humor dynamics in cynomolgus monkeys Curr Eye Res 6 1987 1035 1044
16. BG Dijkstra PF Hoyng Linear relationship of intraocular pressure and flow in anterior segment perfusion in human eyes (abstract) Invest Ophthalmol Vis Sci (Suppl) 35 1994 2051
17. K Erickson-Lamy The perfused human ocular anterior segment as a model for aqueous outflow physiology J Glaucoma 1 1992 44 53
18. 2α increases uveoscleral outflow in the cynomolgus monkey Exp Eye Res 49 1989 389 402
19. BT Gabeh PL Kaufman The effect of prostaglandin on trabecular outflow facility in cynomolgus monkeys Exp Eye Res 51 1990 87 91
20. Y Goh Y Hotehama HK Mishima Characterization of ciliary muscle relaxation induced by various agents in cats Invest Ophthalmol Vis Sci 36 1995 1188 1192
21. Y Goh T Oshima M Araie Mechanism of intraocular pressure reduction observed after topical application of S-1033 in animals Jpn J Ophthalmol 38 1994 228 235
22. M Hayashi ME Yablonski LZ Bito Eicosanoids as a new class of ocular hypotensive agents. 2. Comparison of the apparent mechanism of the ocular hypotensive effects of A and F type prostaglandins Invest Ophthalmol Vis Sci 28 1987 1639 1643
23. 2α-isopropyl ester analogues for glaucoma treatment Jpn J Ophthalmol 37 1993 259 269
24. Y Hotehama HK Mishima Y Kitazawa K Masuda Ocular hypotensive effect of PhXA41 in patients with ocular hypertension or primary open-angle glaucoma Jpn J Ophthalmol 37 1993 270 274
25. PL Kaufman Effects of intracamerally infused prostaglandins on outflow facility in cynomolgus monkey eyes with intact or retrodisplaced ciliary muscle Exp Eye Res 43 1986 819 827
26. PL Kaufman PhXA34-induced ocular hypotension [letter] Arch Ophthalmol 110 1992 1042
27. 2α lowers intraocular pressure L Bito J Stjernschantz The Ocular Effects of Prostaglandins and Other Eiconsanoids 1989 Alan R Liss, Inc New York 387 416
28. 2α-1-isopropylester lowers intraocular pressure without decreasing aqueous humor flow Am J Ophthalmol 105 1988 30 34
29. 2α on aqueous humor dynamics of rabbit, cat, and monkey Invest Ophthalmol Vis Sci 25 1984 1087 1093
30. 2α in human ciliary smooth muscle cells Invest Ophthalmol Vis Sci 35 1994 242 250
31. JD Lindsey K Kashiwagi F Kashiwagi RN Weinreb Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: Implications for uveoscleral outflow Surv Ophthalmol 41 Suppl 2 1997 S53 S59
32. 2α Exp Eye Res 47 1988 761 769
33. HK Mishima Y Kiuchi M Takamatsu Circadian intraocular pressure management with latanoprost: Diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow Surv Ophthalmol 41 Suppl 2 1997 S139 S144
34. 2α-IE) on uveoscleral outflow LZ Bito J Stjernschantz The Ocular Effects of Prostaglandins and Other Eicosanoids 1989 Alan R Liss, Inc New York 429 436
35. 2α-1-isopropylester in the cynomolgus monkey Exp Eye Res 48 1989 707 716
36. 2α effects on isolated rhesus monkey ciliary muscle Invest Ophthalmol Vis Sci 36 1995 2461 2465
37. M Sakurai M Araie T Oshika Effects of topical application of UF-021, a novel prostaglandin derivative, on aqueous humor dynamics in normal human eyes Jpn J Ophthalmol 35 1991 156 165
38. G Selén M Karlsson M Astin Effects of PhXA34 and PhDH100A, two phenyl substituted prostaglandin esters, on aqueous humor dynamics and microcirculation in the monkey eye (abstract) Invest Ophthalmol Vis Sci (Suppl) 32 1991 869
39. 2α analogue Adv Prostaglandin Thromboxane Leukot Res 23 1995 513 518
40. B Svedbergh L Forsberg A morphological study on the effects of chronic administration of latanoprost (LP) on the cilialy muscle and trabecular meshwork in monkeys (abstract) Invest Ophthalmol Vis Sci (Suppl) 34 1993 932
41. H Tetsuka H Tsuchisaka K Kin A mechanism for reducing intraocular pressure in normal volunteers using UF-021, a prostaglandin-related compound Acta Soc Ophthalmol Jpn 96 1992 496 500
42. JE Topper RF Brubaker Effects oftimolol, epinephrine, and acetazolamide on aqueous flow during sleep Invest Ophthalmol Vis Sci 26 1985 1315 1319
43. 2α analogue, on aqueous humor dynamics in human eyes Ophthalmology 100 1993 1297 1304
44. 2 increases uveoscleral outflow and trabecular outflow facility in the cat Exp Eye Res 61 1995 649 657
45. 2α-isopropylester eye drops: Effects in normal eyes Br J Ophthalmol 73 1989 419 426
46. 2α-isopropylester eye drops: Effects on intraocular pressure in open-angle glaucoma Br J Ophthalmol 73 1989 975 979
47. 2-sensitive (DP) agonist, on aqueous humor dynamics after topical application in monkeys and rabbits (abstract) Invest Ophthalmol Vis Sci (Suppl) 32 1991 990
48. 2α on calcium efflux Invest Ophthalmol Vis Sci 33 1992 2679 2686
49. 2α, analogue, after topical application in normal and ocular hypertensive human eyes Arch Ophthalmol 111 1993 1351 1358